Assignee
HEALTHPARTNERS RES FOUNDATION
US·10 granted patents·2 pending applications·87 citations·filing 2001–2013
Top patents by PatentIndex Score
12 records- 0193US7618615B2Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemiaHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Nov 17, 2009·27 cites·13 claims
- 0292US7786166B2Methods and compositions for protecting and treating muscarinic receptors through administration of at least one protective agentHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Aug 31, 2010·16 cites·32 claims
- 0389US7776312B2Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2006·Granted Aug 17, 2010·9 cites·10 claims
- 0489US7084126B1Methods and compositions for enhancing cellular function through protection of tissue componentsHEALTHPARTNERS RES FOUNDATION·Filed 2001·Granted Aug 1, 2006·26 cites·5 claims
- 0586US9205066B2Method of treating parkinson's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 8, 2015·2 cites·11 claims
- 0683US7972595B2Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analogHEALTHPARTNERS RES FOUNDATION·Filed 2005·Granted Jul 5, 2011·4 cites·9 claims
- 0782US9211273B2Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 15, 2015·1 cites·14 claims
- 0882US9211272B2Method of treating lewy body syndrome comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 15, 2015·1 cites·16 claims
- 0979US9216161B2Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted Dec 22, 2015·1 cites·16 claims
- 1069US9345676B2Method of treating stroke comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Granted May 24, 2016·0 cites·27 claims
- 1152US2014057984A1Methods of treating corticobasal degeneration comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Application pending·0 cites
- 1251US2014051763A1Methods of treating frontal temporal dementia (ftd) with comprising administering metal chelators to the upper one-third of the nasal cavityHEALTHPARTNERS RES FOUNDATION·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →